| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 11.088 | 9.466 | 4.790 | 8.932 | 5.900 | 38.802 | 59.565 | 38.417 | 73.939 |
| Total Income - EUR | - | 11.088 | 9.466 | 4.790 | 8.932 | 5.900 | 38.802 | 59.565 | 39.104 | 73.429 |
| Total Expenses - EUR | - | 1.207 | 3.640 | 644 | 4.051 | 2.083 | 3.112 | 7.962 | 15.981 | 28.186 |
| Gross Profit/Loss - EUR | - | 9.881 | 5.826 | 4.146 | 4.881 | 3.818 | 35.690 | 51.603 | 23.123 | 45.243 |
| Net Profit/Loss - EUR | - | 9.548 | 5.542 | 4.002 | 4.613 | 3.650 | 34.526 | 51.007 | 22.740 | 44.016 |
| Employees | - | 1 | 1 | 0 | 0 | 1 | 0 | 1 | 0 | 1 |
Check the financial reports for the company - Bon Vivants Lab S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | 11.005 | 18.479 | 22.745 | 28.324 | 30.853 | 62.464 | 73.870 | 24.763 | 50.500 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 956 | 1.324 |
| Receivables | - | 10.976 | 18.155 | 22.612 | 24.577 | 7.044 | 53.526 | 29.417 | 4.120 | 34.982 |
| Cash | - | 28 | 324 | 133 | 3.747 | 23.808 | 8.938 | 44.453 | 19.687 | 14.194 |
| Shareholders Funds | - | 9.548 | 14.929 | 18.657 | 22.909 | 26.124 | 60.071 | 72.939 | 22.756 | 44.072 |
| Social Capital | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40 |
| Debts | - | 1.456 | 3.550 | 4.088 | 5.415 | 4.728 | 2.393 | 931 | 2.007 | 6.428 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8230 - 8230" | |||||||||
| CAEN Financial Year |
8230
|
|||||||||
Comments - Bon Vivants Lab S.r.l.